Progress in antiretroviral drug delivery using nanotechnology

References

• World Health OrganizationAIDS epidemic update, December 2009. Available at: http://data.unaids.org/pub/Report/2009/JC1700_Epi_Update_2009_en.pdf Accessed on May 12, 2010.
   Google Scholar
• SteinZAHIV prevention: The need for methods women can useAm J Public Health19908044604622316768
   PubMed Web of Science ®Google Scholar
• PauwelsRDe ClercqEDevelopment of vaginal microbicides for the prevention of heterosexual transmission of HIVJ Acquir Immune Defic Syndr Hum Retrovirol19961132112218603257
   PubMedGoogle Scholar
• McGowanIRectal microbicides: A new focus for HIV preventionSex Transm Infect200884641341719028937
   PubMed Web of Science ®Google Scholar
• BoggianoCLittmanDRHIV’s vagina travelogueImmunity200726214514717307703
   PubMed Web of Science ®Google Scholar
• ShattockRJMooreJPInhibiting sexual transmission of HIV-1 infectionNat Rev Microbiol200311253415040177
   PubMed Web of Science ®Google Scholar
• HladikFHopeTJHIV infection of the genital mucosa in womenCurr HIV/AIDS Rep200961202819149993
   PubMedGoogle Scholar
• DomsRWTronoDThe plasma membrane as a combat zone in the HIV battlefieldGenes Dev200014212677268811069884
   PubMed Web of Science ®Google Scholar
• MarechalVPrevostMCPetitCPerretEHeardJMSchwartzOHuman immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosisJ Virol20017522111661117711602756
   PubMed Web of Science ®Google Scholar
• PauzaCDPriceTMHuman immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosisJ Cell Biol198810739599683262112
   PubMed Web of Science ®Google Scholar
• FredericksenBLWeiBLYaoJLuoTGarciaJVInhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virusJ Virol20027622114401144612388705
   PubMed Web of Science ®Google Scholar
• DaeckeJFacklerOTDittmarMTKrausslichHGInvolvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entryJ Virol20057931581159415650184
   PubMed Web of Science ®Google Scholar
• MiyauchiKKimYLatinovicOMorozovVMelikyanGBHIV enters cells via endocytosis and dynamin-dependent fusion with endosomesCell2009137343344419410541
   PubMed Web of Science ®Google Scholar
• HoltgraveDRCauses of the decline in AIDS deaths, United States, 1995–2002 Prevention, treatment or both?Int J STD AIDS2005161277778116336756
   PubMed Web of Science ®Google Scholar
• VyasTKShahLAmijiMMNanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sitesExpert Opin Drug Deliv20063561362816948557
   PubMedGoogle Scholar
• SchragerLKD’SouzaMPCellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapyJAMA1998280167719660366
   PubMed Web of Science ®Google Scholar
• MallipeddiRRohanLCNanoparticle-based vaginal drug delivery systems for HIV preventionExpert Opin Drug Deliv201071374820017659
   PubMed Web of Science ®Google Scholar
• TorchilinVPDrug targetingEur J Pharm Sci2000112S81S9111033430
   PubMed Web of Science ®Google Scholar
• PereraGGreindlMPalmbergerTFBernkop-SchnurchAInsulin-loaded poly (acrylic acid)-cysteine nanoparticles: Stability studies towards digestive enzymes of the intestineDrug Deliv200916525426019538006
   PubMed Web of Science ®Google Scholar
• RaoKSGhorpadeALabhasetwarVTargeting anti-HIV drugs to the CNSExpert Opin Drug Deliv20096877178419566446
   PubMed Web of Science ®Google Scholar
• SharmaPGargSPure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugsAdv Drug Deliv Rev2010624–549150219931328
   PubMed Web of Science ®Google Scholar
• HamASCostMRSassiABDezzuttiCSRohanLCTargeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticlesPharm Res200926350251119002569
   PubMed Web of Science ®Google Scholar
• TakeuchiHYamamotoHKawashimaYMucoadhesive nanoparticulate systems for peptide drug deliveryAdv Drug Deliv Rev2001471395411251244
   PubMed Web of Science ®Google Scholar
• WeberNOrtegaPClementeMICharacterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytesJ Control Release20081321556418727943
   PubMed Web of Science ®Google Scholar
• LiuYFranzenSFactors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticlesBioconjug Chem20081951009101618393455
   PubMed Web of Science ®Google Scholar
• KuoY-CChenH-HEffect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrierInt J Pharm20063271–216016916939704
   PubMed Web of Science ®Google Scholar
• JinSXBiDZWangJWangYZHuHGDengYHPharmacokinetics and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomesPharmazie2005601184084316320946
   PubMed Web of Science ®Google Scholar
• KimSKwonKKwonICParkKNanotechnology in drug delivery: Past, present and futureVilliersMMAramwitPKwonGSNanotechnology in Drug DeliveryNew York, NYSpringer2009
   Google Scholar
• GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience19942635153160016038128245
   PubMed Web of Science ®Google Scholar
• FuKHarrellRZinskiKA potential approach for decreasing the burst effect of protein from PLGA microspheresJ Pharm Sci20039281582159112884245
   PubMed Web of Science ®Google Scholar
• YooHSOhJELeeKHParkTGBiodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained releasePharm Res19991671114111810450940
   PubMed Web of Science ®Google Scholar
• LangerRDrug delivery and targetingNature199839266795109579855
   PubMed Web of Science ®Google Scholar
• SchmidtCLamprechtANanocarriers in drug delivery: Design, manufacture and physicochemical propertiesLamprechtANanotherapeutics – Drug Delivery Concepts in NanoscienceSingaporePan Stanford2009
   Google Scholar
• das NevesJAmijiMMBahiaMFSarmentoBNanotechnology-based systems for the treatment and prevention of HIV/AIDSAdv Drug Deliv Rev2010624–545847719914314
   PubMed Web of Science ®Google Scholar
• ShahiwalaAAmijiMMNanotechnology-based delivery systems in HIV/AIDS therapyFuture HIV Therapy2007114959
   Google Scholar
• du ToitLCPillayVChoonaraYENano-microbicides: Challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDSAdv Drug Deliv Rev2010624–553254619922751
   PubMed Web of Science ®Google Scholar
• KingsleyJDDouHMoreheadJRabinowBGendelmanHEDestacheCJNanotechnology: A focus on nanoparticles as a drug delivery systemJ Neuroimmune Pharmacol20061334035018040810
   PubMed Web of Science ®Google Scholar
• GunaseelanSGunaseelanKDeshmukhMZhangXSinkoPJSurface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugsAdv Drug Deliv Rev2010624–551853119941919
   PubMed Web of Science ®Google Scholar
• WongHLChattopadhyayNWuXYBendayanRNanotechnology applications for improved delivery of antiretroviral drugs to the brainAdv Drug Deliv Rev2010624–550351719914319
   PubMed Web of Science ®Google Scholar
• DembriAMontisciM-JGantierJCChacunHPonchelGTargeting of 3′-azido 3′-deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissuesPharm Res200118446747311451033
   PubMed Web of Science ®Google Scholar
• LobenbergRMaasJKreuterJImproved body distribution of 14C-labelled AZT bound to nanoparticles in rats determined by radioluminographyJ Drug Target1998531711799606007
   PubMed Web of Science ®Google Scholar
• MrsnyRJLessons from nature: “Pathogen-Mimetic” systems for mucosal nano-medicinesAdv Drug Deliv Rev200961217219219146895
   PubMed Web of Science ®Google Scholar
• RekhaMRSharmaCPSynthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorptionJ Control Release2009135214415119331862
   PubMed Web of Science ®Google Scholar
• ThirawongNThongborisuteJTakeuchiHSriamornsakPImproved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexesJ Control Release2008125323624518082282
   PubMed Web of Science ®Google Scholar
• Bernkop-SchnurchAMucoadhesive polymers: Strategies, achievements and future challengesAdv Drug Deliv Rev200557111553155516181704
   PubMed Web of Science ®Google Scholar
• LaiSKWangYYHanesJMucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdv Drug Deliv Rev200961215817119133304
   PubMed Web of Science ®Google Scholar
• LaiSKWangYYWirtzDHanesJMicro- and macrorheology of mucusAdv Drug Deliv Rev20096128610019166889
   PubMed Web of Science ®Google Scholar
• ConeRABarrier properties of mucusAdv Drug Deliv Rev2009612758519135107
   PubMed Web of Science ®Google Scholar
• LaiSKO’HanlonDEHarroldSRapid transport of large polymeric nanoparticles in fresh undiluted human mucusProc Natl Acad Sci U S A200710451482148717244708
   PubMed Web of Science ®Google Scholar
• DestacheCJBelgumTChristensenKShibataASharmaADashACombination antiretroviral drugs in PLGA nanoparticle for HIV-1BMC Infect Dis2009919820003214
   PubMed Web of Science ®Google Scholar
• ShahLAmijiMIntracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDSPharm Res200623112638264516969696
   PubMed Web of Science ®Google Scholar
• MainardesRMGremiaoMPBrunettiILda FonsecaLMKhalilNMZidovudine-loaded PLA and PLA-PEG blend nanoparticles: Influence of polymer type on phagocytic uptake by polymorphonuclear cellsJ Pharm Sci200998125726718425813
   PubMed Web of Science ®Google Scholar
• KuoY-CLoading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticlesInt J Pharm20052901–216117215664142
   PubMed Web of Science ®Google Scholar
• KuoY-CSuF-LTransport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticlesInt J Pharm20073401–214315217418986
   PubMed Web of Science ®Google Scholar
• KuoY-CKuoC-YElectromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriersInt J Pharm20083511–227128117976933
   PubMed Web of Science ®Google Scholar
• PorcelELiehnSRemitaHPlatinum nanoparticles: A promising material for future cancer therapy?Nanotechnology20102188510320101074
   PubMed Web of Science ®Google Scholar
• JainKKNanodiagnostics: Application of nanotechnology in molecular diagnosticsExp Rev Mol Diagn200332153161
   PubMed Web of Science ®Google Scholar
• WangJWangLSunYSurface plasmon resonance biosensor based on Au nanoparticle in titania sol-gel membraneColloids Surf B Biointerfaces201075252052519846285
   PubMed Web of Science ®Google Scholar
• ZhouYYuSHCuiXPWangCYChenZYFormation of silver nanowires by a novel solid-liquid phase arc discharge methodChem Mater1999113545546
   Web of Science ®Google Scholar
• CanizalGAscencioJAGardea-TorresdayJYacamánMJMultiple twinned gold nanorods grown by bio-reduction techniquesJ Nanoparticle Res200135475481
   Web of Science ®Google Scholar
• Yu ChangS-SLeeC-LWangCRCGold nanorods: Electrochemical synthesis and optical propertiesJ Phys Chem B19971013466616664
   Web of Science ®Google Scholar
• SondiISalopek-SondiBSilver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteriaJ Colloid Interface Sci2004275117718215158396
   PubMed Web of Science ®Google Scholar
• LuLSunRWChenRSilver nanoparticles inhibit hepatitis B virus replicationAntivir Ther200813225326218505176
   PubMed Web of Science ®Google Scholar
• SunRWChenRChungNPHoCMLinCLCheCMSilver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cellsChem Commun (Camb)200528405059506116220170
   PubMed Web of Science ®Google Scholar
• WeiDSunWQianWYeYMaXThe synthesis of chitosan-based silver nanoparticles and their antibacterial activityCarbohydr Res2009344172375238219800053
   PubMed Web of Science ®Google Scholar
• Baram-PintoDShuklaSPerkasNGedankenASaridRInhibition of Herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonateBioconjug Chem200920814971502
   PubMed Web of Science ®Google Scholar
• SunLSinghAKVigKPillaiSRSinghSRSilver nanoparticles inhibit replication of respiratory syncytial virusJ Biomed Nanotechnol20084149158
   Web of Science ®Google Scholar
• RogersJParkinsonCChoiYSpeshockJHussainSA preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formationNanoscale Research Letters200834129133
   Web of Science ®Google Scholar
• ElechiguerraJLBurtJLMoronesJRInteraction of silver nanoparticles with HIV-1J Nanobiotechnology20053615987516
   PubMedGoogle Scholar
• LaraHHAyala-NunezNVIxtepan-TurrentLRodriguez-PadillaCMode of antiviral action of silver nanoparticles against HIV-1J Nanobiotechnology20108120145735
   PubMedGoogle Scholar
• BowmanM-CBallardTEAckersonCJFeldheimDLMargolisDMMelanderCInhibition of HIV fusion with multivalent gold nanoparticlesJ Am Chem Soc2008130226896689718473457
   PubMed Web of Science ®Google Scholar
• Braydich-StolleLHussainSSchlagerJJHofmannMCIn vitro cytotoxicity of nanoparticles in mammalian germline stem cellsToxicol Sci200588241241916014736
   PubMed Web of Science ®Google Scholar
• AshaRaniPVLow Kah MunGHandeMPValiyaveettilSCytotoxicity and genotoxicity of silver nanoparticles in human cellsACS Nano20093227929019236062
   PubMed Web of Science ®Google Scholar
• KawataKOsawaMOkabeSIn vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cellsEnviron Sci Technol200943156046605119731716
   PubMed Web of Science ®Google Scholar
• HussainSMHessKLGearhartJMGeissKTSchlagerJJIn vitro toxicity of nanoparticles in BRL 3A rat liver cellsToxicol In Vitro200519797598316125895
   PubMed Web of Science ®Google Scholar
• KimYSKimJSChoHSTwenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley ratsInhal Toxicol200820657558318444010
   PubMed Web of Science ®Google Scholar
• ZhaoJBowmanLZhangXTitanium dioxide (TiO2) nanoparticles induce JB6 cell apoptosis through activation of the Caspase-8/bid and mitochondrial pathwaysJ Toxicol Environ Health, Part A: Current Issues2009721911411149
   PubMed Web of Science ®Google Scholar
• GoodmanCMMcCuskerCDYilmazTRotelloVMToxicity of gold nanoparticles functionalized with cationic and anionic side chainsBioconjug Chem200415489790015264879
   PubMed Web of Science ®Google Scholar
• SvensonSTomaliaDADendrimers in biomedical applications – reflections on the fieldAdv Drug Deliv Rev200557152106212916305813
   PubMed Web of Science ®Google Scholar
• BosmanAWJanssenHMMeijerEWAbout dendrimers: Structure, physical properties, and applicationsChem Rev19999971665168811849007
   PubMed Web of Science ®Google Scholar
• GajbhiyeVPalanirajanVKTekadeRKJainNKDendrimers as therapeutic agents: A systematic reviewJ Pharm Pharmacol2009618989100319703342
   PubMed Web of Science ®Google Scholar
• OkaHOnagaTKoyamaTSyntheses and biological evaluations of carbosilane dendrimers uniformly functionalized with sialyl [alpha](2–>3) lactose moieties as inhibitors for human influenza virusesBioorg Med Chem200917155465547519589684
   PubMed Web of Science ®Google Scholar
• BarnardDLSidwellRWGageTLOkleberryKMMatthewsBHolanGAnti-respiratory syncytial virus activity of dendrimer polyanionsAntiviral Res19973428888(1)
   Google Scholar
• MacriRVKarlovskáJDoncelGFComparing anti-HIV, antibacterial, antifungal, micellar, and cytotoxic properties of tricarboxylato dendritic amphiphilesBioorg Med Chem20091783162316819307123
   PubMed Web of Science ®Google Scholar
• DuttaTGargMJainNKTargeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitroEur J Pharm Sci2008342–318118918501568
   PubMed Web of Science ®Google Scholar
• DuttaTJainNKTargeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimerBiochim Biophys Acta20071770468168617276009
   PubMed Web of Science ®Google Scholar
• HarouseJMKunschCHartleHTCD4-independent infection of human neural cells by human immunodeficiency virus type 1J Virol1989636252725332786088
   PubMed Web of Science ®Google Scholar
• HarouseJMBhatSSpitalnikSLInhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramideScience199125350173203231857969
   PubMed Web of Science ®Google Scholar
• MoulardMLortat-JacobHMondorISelective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120J Virol20007441948196010644368
   PubMed Web of Science ®Google Scholar
• McCarthyTDKarellasPHendersonSADendrimers as drugs: Discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI preventionMol Pharm20052431231816053334
   PubMed Web of Science ®Google Scholar
• Jiang Y-H, EmauPCairnsJSSPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaquesAIDS Res Hum Retroviruses200521320721315795526
   PubMed Web of Science ®Google Scholar
• RuppRRosenthalSLStanberryLRVivaGel (SPL7013 Gel): A candidate dendrimer – microbicide for the prevention of HIV and HSV infectionInt J Nanomedicine20072456156618203424
   PubMed Web of Science ®Google Scholar
• PattonDLCosgrove SweeneyYTMcCarthyTDHillierSLPreclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate modelAntimicrob Agents Chemother20065051696170016641437
   PubMed Web of Science ®Google Scholar
• ChoiYYoshidaTMimuraTSynthesis of sulfated octadecyl ribo-oligosaccharides with potent anti-AIDS virus activity by ring-opening polymerization of a 1,4-anhydroribose derivativeCarbohydr Res199628211131238721740
   PubMed Web of Science ®Google Scholar
• RöyRZaniniDMeunierSJRomanowskaASolid-phase synthesis of dendritic sialoside inhibitors of influenza A virus haemagglutininJ Chem Soc, Chem Commun19932418691872
   Google Scholar
• HanSYoshidaDKanamotoTNakashimaHUryuTYoshidaTSulfated oligosaccharide cluster with polylysine core scaffold as a new anti-HIV dendrimerCarbohydr Polym201080411111115
   Web of Science ®Google Scholar
• BlanzatMTurrinCOPerezERico-LattesICaminadeAMMajoralJPPhosphorus-containing dendrimers bearing galactosylceramide analogs: Self-assembly propertiesChem Commun (Camb)2002171864186512271647
   PubMed Web of Science ®Google Scholar
• BlanzatMTurrinCOAubertinAMDendritic catanionic assemblies: In vitro anti-HIV activity of phosphorus-containing dendrimers bearing galbeta1cer analoguesChembiochem20056122207221316317767
   PubMed Web of Science ®Google Scholar
• Pérez-AnesAStefaniuCMoogCMultivalent catanionic GalCer analogs derived from first generation dendrimeric phosphonic acidsBioorg Med Chem201018124224819942442
   PubMed Web of Science ®Google Scholar
• HeiatiHTawashiRShiversRRPhillipsNCSolid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitateInt J Pharm19971461123131
   Web of Science ®Google Scholar
• HeiatiHTawashiRPhillipsNCSolid lipid nanoparticles as drug carriers: II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate in miceInt J Pharm19981741–27180
   Web of Science ®Google Scholar
• YangSZhuJLuYLiangBYangCBody distribution of camptothecin solid lipid nanoparticles after oral administrationPharm Res199916575175710350020
   PubMed Web of Science ®Google Scholar
• ZaraGPCavalliRFundarÒABargoniACaputoOGascoMRPharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN)Pharmacol Res199940328128610479474
   PubMed Web of Science ®Google Scholar
• ChattopadhyayNZastreJWongHLWuXYBendayanRSolid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell linePharm Res200825102262227118516666
   PubMed Web of Science ®Google Scholar
• ZaraGPCavalliRBargoniAFundaroAVighettoDGascoMRIntravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: Pharmacokinetics and distribution of doxorubicin in brain and other tissuesJ Drug Target200210432733512164381
   PubMed Web of Science ®Google Scholar
• FundaròACavalliRBargoniAVighettoDZaraGPGascoMRNon-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after i.v. administration to ratsPharmacol Res200042433734310987994
   PubMed Web of Science ®Google Scholar
• KuoY-CChenH-HEntrapment and release of saquinavir using novel cationic solid lipid nanoparticlesInt J Pharm20093651–220621318848610
   PubMed Web of Science ®Google Scholar
• LockmanPRKoziaraJMMumperRJAllenDDNanoparticle surface charges alter blood-brain barrier integrity and permeabilityJ Drug Target2004129–1063564115621689
   PubMed Web of Science ®Google Scholar
• PhillipsNCSkameneETsoukasCLiposomal encapsulation of 3′-azido-3′-deoxythymidine (AZT) results in decreased bone marrow toxicity and enhanced activity against murine AIDS-induced immunosuppressionJ Acquir Immune Defic Syndr19914109599661890605
   PubMed Web of Science ®Google Scholar
• PhillipsNCTsoukasCLiposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndromeBlood1992795113711431371411
   PubMed Web of Science ®Google Scholar
• JainSTiwaryAKJainNKSustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: Mechanism of actionCurr Drug Deliv20063215716616611002
   PubMedGoogle Scholar
• JainSTiwaryAKJainNKPEGylated elastic liposomal formulation for lymphatic targeting of zidovudineCurr Drug Deliv20085427528118855596
   PubMedGoogle Scholar
• GuptaUJainNKNon-polymeric nano-carriers in HIV/AIDS drug delivery and targetingAdv Drug Deliv Rev2010624–547849019913579
   PubMed Web of Science ®Google Scholar
• JainSUmamaheshwariRBhadraDJainNEthosomes: A novel vesicular carries for enhanced transdermal delivery of an anti HIV agentInd J Pharm Sci20046617281
   Google Scholar
• JainSTiwaryASapraBJainNFormulation and evaluation of ethosomes for transdermal delivery of lamivudineAAPS PharmSciTech200784249257
   PubMed Web of Science ®Google Scholar
• DubeyVMishraDNaharMJainVJainNKEnhanced transdermal delivery of an anti-HIV agent via ethanolic liposomesNanomedicine2010120 [Epup ahead of print].
   Google Scholar
• PretzerEFlasherDDuzgunesNInhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral proteaseAntiviral Res19973411159107381
   PubMed Web of Science ®Google Scholar
• FlasherDKonopkaKChamowSMLiposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG)Biochim Biophys Acta1994119411851968075135
   PubMed Web of Science ®Google Scholar
• DuzgunesNPretzerESimoesSLiposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cellsMol Membr Biol199916111111810332745
   PubMed Web of Science ®Google Scholar
• SlepushkinVASalemIIAndreevSMDazinPDüzgünesNTargeting of liposomes to HIV-1-infected cells by peptides derived from the CD4 receptorBiochem Biophys Res Comm199622738278338886017
   PubMed Web of Science ®Google Scholar
• GagneJFDesormeauxAPerronSTremblayMJBergeronMGTargeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomesBiochim Biophys Acta20021558219821011779569
   PubMed Web of Science ®Google Scholar
• ClaytonROhagenANicolFSustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomesAntiviral Res200984214214919699239
   PubMed Web of Science ®Google Scholar
• Bestman-SmithJGourdePDésormeauxATremblayMJBergeronMGSterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1Biochim Biophys Acta200014681–216117411018661
   PubMed Web of Science ®Google Scholar
• GargMAsthanaAAgasheHBAgrawalGPJainNKStavudine-loaded mannosylated liposomes: In-vitro anti-HIV-I activity, tissue distribution and pharmacokineticsJ Pharm Pharmacol20065860561616640829
   PubMed Web of Science ®Google Scholar
• GargMGargBRJainSRadiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomesEur J Pharm Sci200833327128118249529
   PubMed Web of Science ®Google Scholar
• GargMJainNKReduced hematopoietic toxicity, enhanced cellular uptake and altered pharmacokinetics of azidothymidine loaded galactosylated liposomesJ Drug Target200614111116603446
   PubMed Web of Science ®Google Scholar
• SathigariSChadhaGLeeYHPhysicochemical characterization of efavirenz-cyclodextrin inclusion complexesAAPS PharmSciTech2009101818719148759
   PubMed Web of Science ®Google Scholar
• YangHParniakMAIsaacsCEHillierSLRohanLCCharacterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781AAPS J200810460661319089644
   PubMed Web of Science ®Google Scholar
• BuchananCMBuchananNLEdgarKJPharmacokinetics of saquinavir after intravenous and oral dosing of saquinavir: hydroxybutenyl-Î2-cyclodextrin formulationsBiomacromolecules20079130531318072746
   PubMed Web of Science ®Google Scholar
• AdamsMLLavasanifarAKwonGSAmphiphilic block copolymers for drug deliveryJ Pharm Sci20039271343135512820139
   PubMed Web of Science ®Google Scholar
• TorchilinVPMicellar nanocarriers: Pharmaceutical perspectivesPharm Res200724111617109211
   PubMed Web of Science ®Google Scholar
• ShaikNPanGElmquistWFInteractions of pluronic block copolymers on P-gp efflux activity: Experience with HIV-1 protease inhibitorsJ Pharm Sci200897125421543318393290
   PubMed Web of Science ®Google Scholar
• BatrakovaEVLiSMillerDWKabanovAVPluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayersPharm Res19991691366137210496651
   PubMed Web of Science ®Google Scholar
• SpitzenbergerTJHeilmanDDiekmannCNovel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitisJ Cereb Blood Flow Metab20072751033104217063148
   PubMed Web of Science ®Google Scholar
• NagasakiYYasugiKYamamotoYHaradaAKataokaKSugar-installed block copolymer micelles: Their preparation and specific interaction with lectin moleculesBiomacromolecules2001241067107011777374
   PubMed Web of Science ®Google Scholar
• SarkerDKEngineering of nanoemulsions for drug deliveryCurr Drug Deliv20052429731016305433
   PubMedGoogle Scholar
• VyasTKShahiwalaAAmijiMMImproved oral bioavailability and brain transport of saquinavir upon administration in novel nanoemulsion formulationsInt J Pharm20083471–29310117651927
   PubMed Web of Science ®Google Scholar
• DouHDestacheCJMoreheadJRDevelopment of a macrophage-based nanoparticle platform for antiretroviral drug deliveryBlood200610882827283516809617
   PubMed Web of Science ®Google Scholar
• DouHMoreheadJDestacheCJLaboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophagesVirology2007358114815816997345
   PubMed Web of Science ®Google Scholar
• DouHGrotepasCBMcMillanJMMacrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDSJ Immunol2009183166166919535632
   PubMed Web of Science ®Google Scholar
• NowacekASMillerRLMcMillanJNanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug deliveryNanomedicine (Lond)20094890391719958227
   PubMed Web of Science ®Google Scholar